AOLS (AOLS) Stock Price & Analysis
AOLS (AOLS) rose 0.00% to USD 0 as of June 10, 2026 at 00:56 UTC, according to Nexqual real-time market data.
AOLS last closed at USD 0; the session ranged USD 0–0 on volume of 100,000 shares. Market capitalization is $15,208, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 00:56 UTC.
Key Statistics (as of June 10, 2026 at 00:56 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 100,000 shares |
| Market Cap | $15,208 |
| Exchange | PNK |
Technical Analysis (AOLS)
Nexqual's technical model rates AOLS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:56 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (AOLS)
Wall Street analysts rate AOLS "None", per Nexqual as of June 10, 2026 at 00:56 UTC.
| Consensus Rating | None |
|---|
Earnings (AOLS)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2015-06-30 | USD -0.01 vs est 0 ▼ miss |
| 2015-03-31 | USD -0.01 vs est 0 ▼ miss |
| 2014-12-31 | USD -0.01 vs est 0 ▼ miss |
| 2014-09-30 | USD 0 vs est 0 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Financials & Fundamentals (AOLS)
| Total Revenue | $771,000 |
|---|---|
| Revenue Growth (YoY) | -98.00% |
| Gross Margin | -223.22% |
| Operating Margin | -7300.00% |
| Profit Margin | +0.00% |
| ROE | -186.43% |
| Current Ratio | 1.3 |
| Total Cash | $403,000 |
| Total Debt | $0 |
| Free Cash Flow | $-1.81M |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Financial Health Score (AOLS)
Nexqual rates AOLS's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:56 UTC.
| Growth | Strong — Revenue +145% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $403K cash, no debt |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Critical — ROE -186%, ROA -90.3% |
Ownership (AOLS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 152.09M |
| Float | 47.04M |
Source: Nexqual, June 10, 2026 at 00:56 UTC.
Leadership (AOLS)
AOLS is led by Christopher Stanley, Vice President of Operations, per Nexqual as of June 10, 2026 at 00:56 UTC.
| Vice President of Operations | Christopher Stanley |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCEL | Cryo-Cell International, Inc. | USD 3.45 | ▼ 1.43% |
| MCET | MULTICELL TECHNOLOGIES INC | USD 0 | ▲ 0% |
| ARYX | ARYX THERAPEUTICS INC | USD 0 | ▲ 0% |
| NPHC | Nutra Pharma Corp. | USD 0 | ▲ 50% |
| ACUR | ACURA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:56 UTC. This page is informational and not investment advice.